Friday, October 9, 2020

Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does: study

Virologists have shown that a treatment with the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose of the anti-flu drug favipiravir, by contrast, has an antiviral effect in the hamsters.

from Latest Science News -- ScienceDaily https://ift.tt/3iLSmWr
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

The hidden atomic gap that could break next-generation computer chips

A major obstacle may be standing in the way of the next generation of ultra-tiny computer chips. Researchers discovered that many promising ...